Bio Green Med Solution, Inc. (BGMS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bio Green Med Solution, Inc. on January 12, 2026. The Company is incorporated in Delaware and maintains its principal executive offices in Kuala Lumpur, Malaysia. It is listed on The Nasdaq Capital Market under the symbols BGMS (Common Stock) and BGMSP (Preferred Stock).
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on a specific corporate action regarding preferred stock dividends.
Material Changes and Events
Under Item 8.01 (Other Events), the Board of Directors declared a quarterly cash dividend on the Company's 6% Convertible Exchangeable Preferred Stock. The key details are:
- Dividend Amount: $0.15 per share.
- Record Date: January 22, 2026.
- Payment Date: February 1, 2026.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies beyond the dividend declaration. No unusual items were reported.
Investor Verification Checklist
- Verify the record date of January 22, 2026, to ensure eligibility for the $0.15 per share dividend.
- Confirm the payment date of February 1, 2026, for cash flow planning.
- Review the terms of the 6% Convertible Exchangeable Preferred Stock to understand conversion rights and seniority.
- Check subsequent filings for any changes to the dividend schedule or payment status.